- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04543448
Effect of Cervical Mobilization on Balance and Plantar Pressure Distribution in Multiple Sclerosis
Investigation the Effect of Cervical Mobilization on Balance and Plantar Pressure Distribution in Multiple Sclerosis Patients: A Randomized Crossover Controlled Study
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Gaziantep, Turkey
- Hasan Kalyoncu University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Expanded Disability Status Scale (EDSS) score was between 2-5,
- According to the modified Ashworth Scale, spasticity is between 1 and 3,
- EDSS Cerebellar System Sub-Scale, Functional System Score ˃1,
- medical condition is stable and no medication changes were made in the last month,
- Vertebro-basillar test negative,
- Not have any other neurological disorder and orthopedic problem to prevent participation in this study
- A score of at least 24 from the Mini Mental Test,
Exclusion Criteria:
- presence of psychiatric or severe cognitive dysfunction,
- pregnancy,
Having a neurological disease other than MS,
- having had an attack in the last 3 months,
- Botulinum toxin application within the last 6 months,
- participating in physiotherapy program in the last 6 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Traditional Rehabilitation
Traditional Rehabilitation program was included strengthening exercises for the muscles needed, balance and coordination exercises according to the individual's level, stretching for the lower limbs in all individuals.
Indıvıduals participated in 2 training sessions per week for 4 weeks.
Each training session consisted of a 5-minute non-balance coordination exercise, a 30-minute balance and coordination exercise, a 10-minute stretching and strengthing.
|
Traditional rehabilitation program include strengthening exercises for the muscles needed, balance and coordination exercises according to the individual's level, stretching for the lower limbs.
Other Names:
|
EXPERIMENTAL: Cervical Mobilization
Cervical Mobilization program, cervical mobilization techniques were applied to the patients for 30 minutes in addition to the traditional program.
Cervical mobilization includes suboccipital relaxing techniques, myofascial muscle relaxing techniques for Levator scapula, trapezius, scalenes muscles.
These techniques were applied bilaterally.
|
Cervical mobilization program include myofascial relaxation techniques and mobilization to cervical spine in addition to traditional program.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change Plantar Pressure Distribution
Time Frame: Change from plantar pressure distribution at one month
|
Pedobarography system was used for plantar pressure analyses.
Pedobarography system contains screen, color printer, pressure sensor platform, remote control device, power unit, printer-to-platform and screen-to-platform connections.
The maximum and mean pressure in the foot, the percentages of pressure values in the fore and rear of the foot, percentages of the total pressure falling to the foot were evaluated.
As higher values mean higher load.
|
Change from plantar pressure distribution at one month
|
Change Balance
Time Frame: Change from plantar pressure distribution at one month
|
Romberg test (RT) was performed on the patients with eyes closed and feet together. When the participant held it in one place, the test was terminated, oscillations began, or was likely to fall. Romberg test's maximum duration was 120 sec. RT is clinically used for vestibular problems. Sharpened Romberg (SR) was performed on a straight line with one leg behind the other leg, eyes open, leaving the arms sagging and without impairing the balance. Duration stop criteria were defined as the time that took a participant to dislocate the foot, reach the maximal duration of 30 sec, and contact the observer to avoid falling. Individuals' dynamic balance was evaluated with the Functional Reach Test (FRT). Individuals had requested their hands at 90 degrees by keeping the dominant arms' elbow straight on the wall. The test was performed as reaching forward without taking a step and losing the balance on the wall. The metacarpal bone level was marked in the start position and final position |
Change from plantar pressure distribution at one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change Modified ashworth scale
Time Frame: Change from Modified ashworth scale at one month
|
Modified Ashworth Scale measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity.
The minimum value is 1 and the maximum value is 4. Whether higher scores mean a worse outcome
|
Change from Modified ashworth scale at one month
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: KEZBAN BAYRAMLAR, Prof. Dr., Hasan Kalyoncu University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Neurologic Manifestations
- Musculoskeletal Diseases
- Muscular Diseases
- Neuromuscular Manifestations
- Muscle Hypertonia
- Multiple Sclerosis
- Sclerosis
- Muscle Spasticity
Other Study ID Numbers
- 2019/0107
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
Clinical Trials on Traditional Rehabilitation for multiple sclerosis
-
University of Alabama at BirminghamNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis, Relapsing-Remitting | Sexual DysfunctionUnited States
-
Università degli Studi di SassariCompletedMultiple Sclerosis | Fatigue | WeaknessItaly
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedMultiple SclerosisUnited States
-
University of Illinois at ChicagoBristol-Myers Squibb; University of Alabama at BirminghamRecruiting
-
US Department of Veterans AffairsCompleted
-
Sunnybrook Health Sciences CentreMultiple Sclerosis Society of CanadaUnknown
-
Alper PercinCompletedTemporomandibular Joint Dysfunction Syndrome | Autonomic Nervous System ImbalanceTurkey
-
Duke UniversityCompleted
-
Nantes University HospitalTerminated